BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26057862)

  • 1. S100A4 and its role in metastasis – simulations of knockout and amplification of epithelial growth factor receptor and matrix metalloproteinases.
    Buetti-Dinh A; Pivkin IV; Friedman R
    Mol Biosyst; 2015 Aug; 11(8):2247-54. PubMed ID: 26057862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A4 and its role in metastasis – computational integration of data on biological networks.
    Buetti-Dinh A; Pivkin IV; Friedman R
    Mol Biosyst; 2015 Aug; 11(8):2238-46. PubMed ID: 26118552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF.
    Jia W; Gao XJ; Zhang ZD; Yang ZX; Zhang G
    Eur Rev Med Pharmacol Sci; 2013 Jun; 17(11):1495-508. PubMed ID: 23771538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13.
    Wang L; Wang X; Liang Y; Diao X; Chen Q
    Acta Biochim Pol; 2012; 59(4):593-8. PubMed ID: 23162804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by upregulation of S100A4/MMPs signaling.
    Cao WH; Liu HM; Liu X; Li JG; Liang J; Liu M; Niu ZH
    Eur Rev Med Pharmacol Sci; 2013 Mar; 17(5):609-17. PubMed ID: 23543443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme.
    Bjørnland K; Winberg JO; Odegaard OT; Hovig E; Loennechen T; Aasen AO; Fodstad O; Maelandsmo GM
    Cancer Res; 1999 Sep; 59(18):4702-8. PubMed ID: 10493528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
    Zhang J; Zhang DL; Jiao XL; Dong Q
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy.
    Sherbet GV
    Cancer Lett; 2009 Jul; 280(1):15-30. PubMed ID: 19059703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of matrix metalloproteinases and the metastasis-associated gene S100A4 in human neuroblastoma and primitive neuroectodermal tumor cells.
    Bjørnland K; Bratland A ; Rugnes E; Pettersen S; Johansen HT; Aasen AO; Fodstad Ø; Ree AH; Maelandsmo GM
    J Pediatr Surg; 2001 Jul; 36(7):1040-4. PubMed ID: 11431772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional interaction between Smad3 and S100A4 (metastatin-1) for TGF-beta-mediated cancer cell invasiveness.
    Matsuura I; Lai CY; Chiang KN
    Biochem J; 2010 Feb; 426(3):327-35. PubMed ID: 20070253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metastasis associated protein S100A4: role in tumour progression and metastasis.
    Helfman DM; Kim EJ; Lukanidin E; Grigorian M
    Br J Cancer; 2005 Jun; 92(11):1955-8. PubMed ID: 15900299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro.
    Cui JF; Liu YK; Zhang LJ; Shen HL; Song HY; Dai Z; Yu YL; Zhang Y; Sun RX; Chen J; Tang ZY; Yang PY
    Proteomics; 2006 Nov; 6(22):5953-61. PubMed ID: 17051636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin (alpha6beta4) signals through Src to increase expression of S100A4, a metastasis-promoting factor: implications for cancer cell invasion.
    Kim TH; Kim HI; Soung YH; Shaw LA; Chung J
    Mol Cancer Res; 2009 Oct; 7(10):1605-12. PubMed ID: 19808905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9.
    Saleem M; Kweon MH; Johnson JJ; Adhami VM; Elcheva I; Khan N; Bin Hafeez B; Bhat KM; Sarfaraz S; Reagan-Shaw S; Spiegelman VS; Setaluri V; Mukhtar H
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14825-30. PubMed ID: 16990429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypomethylation-induced expression of S100A4 increases the invasiveness of laryngeal squamous cell carcinoma.
    Liu J; Guo Y; Fu S; Yang M; Sun KL; Fu WN
    Oncol Rep; 2010 Apr; 23(4):1101-7. PubMed ID: 20204297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A4 is expressed at site of invasion in rheumatoid arthritis synovium and modulates production of matrix metalloproteinases.
    Senolt L; Grigorian M; Lukanidin E; Simmen B; Michel BA; Pavelka K; Gay RE; Gay S; Neidhart M
    Ann Rheum Dis; 2006 Dec; 65(12):1645-8. PubMed ID: 17105852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of S100A4, a metastasis-associated protein, in endothelial cells inhibits tumor angiogenesis and growth.
    Ochiya T; Takenaga K; Endo H
    Angiogenesis; 2014 Jan; 17(1):17-26. PubMed ID: 23929008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma.
    Zou M; Al-Baradie RS; Al-Hindi H; Farid NR; Shi Y
    Br J Cancer; 2005 Nov; 93(11):1277-84. PubMed ID: 16265347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100A4, frequently overexpressed in various human cancers, accelerates cell motility in pancreatic cancer cells.
    Sekine H; Chen N; Sato K; Saiki Y; Yoshino Y; Umetsu Y; Jin G; Nagase H; Gu Z; Fukushige S; Sunamura M; Horii A
    Biochem Biophys Res Commun; 2012 Dec; 429(3-4):214-9. PubMed ID: 23085231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of S100A4 gene expression inhibits in vitro invasiveness of human squamous cell carcinoma, KOSC-3 cells.
    Uozumi M; Murao S; Katayama N; Kitazawa S; Amatsu M; Maeda S
    Cancer Lett; 2000 Feb; 149(1-2):135-41. PubMed ID: 10737717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.